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We report a device to fill an array of small chemical reaction chambers (microreactors) with reagent and
then seal them using pressurized viscous liquid acting through a flexible membrane. The device enables
multiple, independent chemical reactions involving free floating intermediate molecules without
interference from neighboring reactions or external environments. The device is validated by protein
expressed in situ directly from DNA in a microarray of ,10,000 spots with no diffusion during three
hours incubation. Using the device to probe for an autoantibody cancer biomarker in blood serum
sample gave five times higher signal to background ratio compared to standard protein microarray
expressed on a flat microscope slide. Physical design principles to effectively fill the array of
microreactors with reagent and experimental results of alternate methods for sealing the microreactors
are presented.
B
iology experiments in the early 20th century were performed one at a time in glassware such as test tubes,
petri dishes or flasks. In themiddle of the century immunoassays, based on 96-well plastic microtiter plates,
were prototypical parallel biology experiments1. Currently around a million experiments are performed
simultaneously for gene expression analysis2 and around a billion for next generation DNA sequencing3. These
high throughput experiments are based on molecules tethered to a surface. However chemical reactions in living
cells involve untethered, free floatingmolecules in aqueous solutions. Many different biochemical reactions occur
simultaneously depending on cell type, cell cycle or external stimuli. Unravelling this complexity and its effect on
human health requires high throughput experimental platforms that can simultaneously study thousands of
biochemical reactions involving untethered, free floating, molecular compounds.
Protein expression in living cells involves untethered intermediate molecules such as mRNA, enzymes, ribo-
somes, amino acids and polypeptides. Proteins can also be expressed outside of living cells by subjecting gene
DNA to ‘cell-free’ in vitro coupled transcription and translation (IVTT) reagent. This is the process used for
nucleic acid programmable protein arrays (NAPPA)4,5 to express unique proteins from plasmid DNA containing
their full length genes. Proteins are expressed and captured in situ in amicroarray format at the time of assay. The
microarrays are used to assay thousands of protein interactions simultaneously to discover autoantibody bio-
markers correlated to specific diseases6–12 and to detect antibodies to pathogens13,14. To preserve protein function,
assays using NAPPA are typically done within hours of expressing fresh proteins without ever allowing them to
dry out. Contrast this with conventional proteinmicroarrays based on purified proteins printed from frozen stock
and then stored possibly for months before assay.
In situ protein expression for NAPPA is typically carried out on flat microscope slides by flooding the entire
microarray surface with IVTT reagent. Spot to spot diffusion currently limits NAPPA density to,2,500 protein
spots per slide. Density can be increased by expressing proteins in an array of micro reaction chambers (micro-
reactors)15. We report a novel device to reliably fill all of the microreactors with reagent and then completely seal
them. The device is amenable to production scale processing of microreactor array slides.
Results
Microreactor array processing overview. Themicroreactor array platform consists of an array of functionalized
microreactors in amicroscope slide format and a device for filling themicroreactors with reagent and then sealing
them. Microreactor array slides (slides) are fabricated from silicon wafers using standard isotropic wet etch
process with details provided in Methods. Microreactors are 270 mm across, 70 mm deep and 375 mm apart.
There are,14,000 microreactors in a hexagonal array pattern on a single 25.4 mm3 76.2 mmmicroscope slide
format. The silicon surface is oxidized with 95 nanometer silicon dioxide (SiO2) which is the main component of
glass. Thismakes the silicon slide compatible with conventional surface chemistry for functionalizing glass. It also
prevents fluorescent signal quenching of bare silicon. Individual microreactors are filled with different unique
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functionalizing chemicals using non-contact piezoelectric inkjet
dispensing technology15–17. Portions of these chemicals are bound
to the functionalized surfaces of the microreactors. Dried printed
slides may be stored for later processing. The slides may be soaked
in a blocking buffer to wash away remaining unbound chemicals and
to mitigate nonspecific binding. A centrifuge or vacuum chamber is
used to force entrapped air out of the microreactors and fill them
with the blocking buffer. After rinsing and drying, slides are inserted
into the fill & seal device, Figure 1. An O-ring is placed around the
periphery of the slide for vacuum or pressure sealing. A transparent,
flexible, impenetrable, smooth, sealing membrane is placed over the
O-ring and slide. A transparent window is placed over the sealing
membrane and the assembly is clamped together in a rigid frame
using fasteners.
Approximately 300 ml of degassed reagent is injected into a reagent
inlet/outlet port and forced through a thin fluid gap between the slide
and sealing membrane. Vacuum is applied to the fluid gap, through a
reagent outlet port, before injecting the reagent. Microreactors are
filled with reagent at a rate of greater than 10,000 microreactors per
second. The functionalizing chemicals stay in place during filling
since they are bound to the surface. High viscosity, pressurized, in-
compressible, sealing liquid is injected onto the sealing membrane
through an inlet port in the window. The sealing membrane wipes
excess reagent from the slide surface as the sealing liquid spreads out
across the membrane. Excess reagent is forced out through inlet or
outlet reagent ports and ,200 ml may be recovered. After spreading
out across the whole surface, the pressurized sealing liquid continues
to apply even pressure onto the slide surface through the sealing
membrane. This uniformly seals all of the microreactors into isolated
reaction containers.
The process of filling and sealing all of the microreactors takes less
than five seconds. It is actuated entirely by opening or closing valves
and is therefore amenable to automation via electronic actuators.
Reagent reacts with functionalizing chemicals in the microreactors
possibly creating untethered intermediate molecules that are con-
tained for extended incubation periods. After incubation, the slide
is removed from the fill & seal device for further chemical processing
such as washing, blocking or labeling. To preserve molecular func-
tionality, the slide is typically never allowed to dry out during an
assay. The whole slide may be flooded with sample fluid to detect
probe (query) molecules by their affinity to specific chemical pro-
ducts (targets) in the microreactors. After chemical processing the
slide may be dried and imaged using a fluorescent microarray scan-
ner for example.
Alternate methods for sealingmicroreactors. Three alternate methods
for sealing microreactors were evaluated. Devices were fabricated
to test the alternate methods. The alternate methods use the same
process of filling microreactors with reagent as the preferred device of
Figure 1. All of the alternate methods also use a sealing membrane but
differ in how they actuate the membrane, either by: 1) silicone rubber,
2) gas or 3) hydraulic oil. Figure 2 is a schematic representation of the
device based on silicone rubber. It is similar to the device reported
previously15 with the addition of the reagent outlet port and the seal-
ing membrane. The reagent outlet port enables applying vacuum sepa-
rately from the inlet port. Previously15 vacuum was applied through
Figure 1 | Schematic of preferred microreactor array fill & seal device. (A) Top view schematic of device consisting of a rigid frame with fasteners
clamping a transparent window and transparent sealingmembrane onto anO-ring sealing around the perimeter of amicroreactor array slide consisting of
microreactors with functionalizing chemicals. There are inlet & outlet ports for reagent at the bottom and inlet & outlet ports for sealing liquid at the
top. Features are not drawn to scale. (B) Section view schematic of same device illustrating the process of displacing excess reagent and sealing
microreactors. After completely filling themicroreactors, excess reagent is displaced from the slide by pressurized sealing liquid injected through a sealing
liquid inlet port acting on a sealing membrane. As the sealing liquid spreads out across the sealing membrane it first displaces excess reagent though
reagent inlet & outlet ports and then seals the microreactors into isolated chemical reaction containers. The schematics (A, B) were drawn by Peter
Wiktor.
www.nature.com/scientificreports
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the reagent at the inlet port. This introduced air into the reagent which
interfered with filling of the microreactors. The sealing membrane
isolates the microreactors from the porous silicone rubber and thus
reduces diffusion after sealing the microreactors. The other two alter-
nate methods are similar to Figure 1 with either gas or hydraulic oil
replacing the viscous sealing liquid. Pros and cons of the various
approaches are summarized in Discussion.
Experimental evaluation of fill & seal methods. The alternate fill &
seal methods were experimentally evaluated for NAPPA and com-
pared to the preferred method of Figure 1 and to flat glass. Printing
mixture, containing capture antibodies, is printed into microreactors
followed by plasmid DNA. To clearly detect diffusion, spots contain-
ing printing-mixture & plasmid DNA are surrounded by spots con-
taining just the printing-mixture. Any expressed proteins that diffuse
away from a DNA spot are captured by the antibodies in neighboring
spots and therefore easily detected. Fluorescently labeled proteins ex-
pressed from the DNA are displayed in the subarrays of Figure 3. The
top subarray (A) was expressed using the preferred fill & seal device of
Figure 1. There is negligible signal in the adjacent spots indicating
negligible diffusion and capture of expressed proteins. This is signifi-
cant since the signal at a given spot is due exclusively to the analyte
at that spot and not from its neighbors. This reduces false positives
during data analysis. Brightness and contrast are adjusted at the right
third of the subarray in Figure 3A to show actual printing density and
locations of the adjacent spots.
Standard NAPPA on flat glass is compared to NAPPA on micro-
reactor array in Figure 3B. The same set of plasmid DNAwas printed
on flat glass (B) at the same time as microreactor arrays (A). Printing
conditions were optimized for microreactor arrays. Genes were
expressed into their corresponding proteins by flooding the whole array
with IVTT reagent and then incubating for three hours. Proteins on the
substrates in (A) and (B) were fluorescently labeled, scanned and
displayed using identical conditions. There is more diffusion on flat
glass (B) vs. microreactor array (A). However standard NAPPA
typically has lower diffusion if the printing conditions are optimized
for flat glass11. Normally, for standard NAPPA, mixtures of higher
concentration DNA & printing mixture are printed using a pin-
spotter at four times lower spot density. Diffusion on flat glass is
much lower under these standard conditions.
Protein subarrays expressed using the three alternative methods:
silicone rubber, gas and hydraulic oil are shown in Figure 3 (C, D and
E) respectively. Signal to background ratio of the various sealing
methods are plotted in Figure 4.
Figure 2 | Schematic of silicone rubber based fill & seal device. Section
view schematic of alternate microreactor fill & seal device based on sealing
microreactors using silicone rubber instead of a viscous sealing liquid.
Features are not drawn to scale. The schematic was drawn by PeterWiktor.
Figure 3 | Fluorescent microarray scanner images of NAPPA subarrays
for different sealing methods. Enlargements of fluorescent microarray
scanner images of nucleic acid programmable protein arrays (NAPPA)
subarrays processed using five different methods of sealing microreactors.
Bright spots are fluorescently labeled proteins expressed in situ from
plasmid DNA using in vitro coupled transcription translation (IVTT)
reagent. Proteins are captured at each spot with a printing mixture
containing capture antibodies. Spots adjacent to the bright spots just have
the printing mixture without DNA. Therefore signal in adjacent spots
indicates diffusion from the spots containing DNA. The five subarrays
correspond to the following five sealing methods: (A) viscous liquid,
(B) no sealing i.e flat glass, (C) silicone rubber, (D) gas, (E) hydraulic oil.
Brightness and contrast of the right third of subarray (A) is separately
adjusted to show actual printing density and locations of the adjacent
spots. Brightness and contrast of the image as a whole is adjusted to help
visualize diffusion to compare the different methods.
Figure 4 | Comparison chart of microreactor sealing methods. Signal to
background ratio of fluorescently labeled protein spots using five different
microreactor sealing methods are shown. Signal is the average of the
median pixel intensity of the protein spots from the subarrays in Figure 3.
Background is the average of the median pixel intensity of the adjacent
spots. Proteins were expressed in situ in amicroarray format using NAPPA
chemistry.
www.nature.com/scientificreports
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Validation of microreactor arrays as a clinical screening platform.
Some cancer patients produce autoantibodies against p53, a tumor
suppressor protein18. These autoantibodies can be detected in blood
serum samples using immunoassays such as enzyme-linked immuno-
sorbent assay (ELISA) or NAPPA. NAPPA has dynamic range and
limit of detection comparable to ELISA19. We compared sensitivity of
detecting anti-p53 autoantibodies using NAPPA on microreactor
array vs. flat glass. Full length genes for p53 protein were printed on
both microreactor array and flat glass and processed as described in
Methods. Printing conditions were optimized for their respective sub-
strates, i.e. piezoelectric dispensing for microreactor arrays and pin-
spotting for flat glass. The two types of substrates were then probed
with serum sample from the same colon cancer patient at four serum
dilutions from 1550 to 15900. Signal to background ratio of anti-P53
response is five times higher for NAPPA on microreactor array vs.
standard flat glass, Figure 5. Signal to background ratios in Figure 5 are
much lower than Figure 4 since serum has many different proteins
that bind nonspecifically to the surface and increase background.
A bitmap image rendered in fluorescently labeled p53 protein
expressed in microreactors from plasmid DNA for the p53 gene is
shown in Figures 6. The image illustrate fidelity of the microreactor
array platformwith density greater than 10,000 protein spots expressed
on a single microscope slide format with no diffusion or evaporation
during three hours incubation. Moreover, the ability to control differ-
ent protein levels by adjusting the amount of printed DNA, demon-
strates the nuanced ability of these microreactors to test reactions
under quantitative conditions.
Discussion
Previous work. The microreactor array is a synergy of microplate
andmicroarray technology. It miniaturizes microplates1 down to the
scale of microarrays20–24 allowing tens of thousands independent
biochemical reactions simultaneously on a single microscope slide
format. It is based on an array of microreactors that are accessed in
parallel by a thin sheet of reagent and then sealed by viscous liquid
acting through a flexible sealing membrane. To our knowledge, this
micofluidic configuration is the first of its kind. It does not follow the
conventional ‘lab-on-a-chip’ paradigm, i.e. a miniaturized, serial, 2D
network of micro-channels emulating an electronic circuit or conven-
tional chemical processing plant. Such platforms are also known as
‘micro total analysis systems’ (mTAS), ‘micro electrical mechanical
systems’ (MEMS) or ‘microreactors’25–29. They were originally deve-
loped for polymerase chain reaction (PCR)30,31. Various planar micro-
reactor array type platforms have also been developed for PCR32–43 and
other life science applications44–52 but none use the unique microflui-
dic configuration presented here. Cell-free in vitro protein expression
has been done in various microreactor formats53–59 but never using the
present configuration for filling and sealing the microreactors.
Microreactor filling. Physical design principles to effectively fill
the array of microreactors with reagent are presented based on fluid
mechanics nondimensional analysis. Reagents in the life sciences are
typically aqueous solutions. Water has high surface tension which do-
minates other forces at the small dimensions of microreactors making
them difficult to fill with reagent. For the microreactor array platform,
reagent is forced into microreactors by first applying vacuum to a thin
fluid gap between themicroreactor array slide surface and sealingmem-
brane and then quickly injecting reagent, under pressure, into this
gap. This approach fills microreactors by overcoming surface tension
through a combination of vacuum, pressure, inertial, wetting and
viscous forces. Kinetic and potential energy of the reagent overcomes
its surface energy. Similar issues, concerning filling small features
with fluids, arise in other fields such as plastic injection molding and
microimprint lithography60.
Figure 5 | Signal to background ratio of antibody response in patient
blood serum sample. Signal to background ratio of anti-p53 antibody
response in cancer patient blood serum detected on NAPPA microreactor
array vs. standard NAPPA on flat microscope slides. The height of the bar
for each dilution point is the average signal to background ratio of six spots
on the arrays. Error bars indicate signal range for the six spots. Signal of
each spot is the median pixel value of the spot. Background is the median
signal of all of the spots on the array. Figure 6 | Image rendered with proteins expressed from DNA in
microreactors. Four concentrations of plasmid DNA for the p53 gene are
printed into small chemical reaction chambers (microreactors) on a
microscope slide format using a PiXY piezoelectric dispensing instrument.
Proteins are expressed in situ from the DNA using in vitro coupled
transcription and translation (IVTT) reagent. Microreactors are sealed
during three hours protein expression to prevent diffusion. Varying
concentrations of DNA produce varying signal intensities of fluorescently
labeled protein spots. Black spots are empty. The image has,12 kilopixel
resolution (108 3 108 spots). It was initially split in half to print on a
microscope slide format. Original photograph of Albert Einstein by
Philippe Halsman (c) Halsman Archive.
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 5 : 8736 | DOI: 10.1038/srep08736 4
Weber number We~
pdv2
c
characterizes relative influence of
inertia vs. surface tension of fluid with density r and surface tension
c flowing with velocity v in a channel with hydraulic diameter d.
Weber number is used to analyze thin film flows and the formation
of droplets and bubbles61. The Weber number for the microreactor
array platform is We > 0.02 meaning that inertial forces have low
influence on filling microreactors compared to surface tension.
Capillary number Ca~
mv
c
characterizes relative influence of vis-
cous vs. surface tension forces. The microreactor array platform has
low capillary number Ca > 0.001 meaning that reagent flow
dynamics at velocity v are heavily influenced by surface tension c
compared to dynamic viscosity m. The following key conditions are
identified for complete filling of small features62: highCapillary num-
ber, low aspect ratio features and high surface wetting of the features
vs. the opposing surface. Aspect ratio is relative depth to width ratio
of microreactors. Generally, aspect ratios less than one are required
for complete filling of microreactors62. A higher wetting (hydro-
philic) microreactor array slide surface compared to the opposing
surface (hydrophobic) promotes filling of the microreactors63.
Reynolds number Re~
rdv
m
characterizes relative influence of
inertial vs. viscous forces. Physical design parameters are inter-
dependent and must be balanced for good filling of the microreac-
tors. High reagent injection velocity increases Capillary number to
help overcome surface tension with viscous forces. However Weber
number also increases with velocity resulting in incomplete filling of
microreactors due to inertial forces which can break up reagent
flow62. This manifests itself as foaming and is exacerbated by gas
dissolved in the reagent. Inertia can also cause reagent to skim across
the top of the microreactors instead of flowing down into them.
Complete filling of microreactors is therefore assisted by relatively
low Weber number and relatively high Capillary number. The ratio
of Weber to Capillary numbers also corresponds to Reynolds num-
ber Re~
We
Ca
which should therefore be low for complete filling of
microreactors. Regent flow in the fluid gap of the microreactor array
platform has relatively low Reynolds number Re > 20 resulting in
laminar flow. Low Reynolds number corresponds to low reagent
injection velocity v high kinematic viscosity
m
r
and small reagent
fluid gap
d
2
.
Physical parameter values for water are used here to calculate the
non-dimensional numbers. Filling microreactors with actual
reagents may be assisted by thickening agents to increase viscosity
(lower Re) or surfactants to decrease surface tension (higher Ca).
Small concentrations of surfactants can dramatically decrease sur-
face tension.
Microreactor sealing. Microreactors are sealed with viscous liquid
acting through a flexible sealing membrane, Figure 1. Viscous liquid
has the appropriate combination of physical properties to seal the
microreactors: incompressible flow to displace excess reagent from
the microreactor array surface followed by isotropic pressure to seal
all of the microreactors uniformly. This is the first time that viscous
liquid is used in this manner and is a key advancement for this
process. It provides a simple elegant solution to a challenging problem.
As shown in Figures 3 & 4, alternate methods for sealing micro-
reactors are not effective in preventing diffusion between microreac-
tors. Using silicone rubber is the best alternate method but it is not
completely effective. Silicone rubber presses down uniformly on the
microreactor surface invariably entrapping reagent in small pockets
that prevent complete sealing of the microreactors in those areas.
Using either gas or hydraulic oil is not effective since each one quickly
spreads out across the sealing membrane entrapping a layer of
reagent that again prevents complete sealing of the microreactors.
Compared to the preferred method of using viscous sealing liquid,
the alternate methods clearly demonstrate the need for an effective
means of first wiping reagent away from the surface before sealing the
microreactors.
Conclusion. For NAPPA, the microreactor array platform provides
an array of miniaturized reaction chambers that can be individually
programmed to produce any desired protein. NAPPA is commonly
used to screen antibody affinity to those proteins in serum samples
from healthy vs. diseased individuals. Themicroreactor array platform
has higher signal to background ratio of antibody response compared
to standard NAPPA on flat microscope slides, Figure 5. It can there-
fore detect serum antibodies with higher sensitivity and potentially
improve the accuracy of clinical studies correlating antibody response
to disease.
Methods
Methods to generate NAPPA protein microarrays using microreactor arrays with the
preferred fill & seal device of Figure 1 are presented. Methods to screen for antibodies
in patient serum samples and analyze the results are also presented.
Fabricate microreactor arrays. Take appropriate safety precautions. To
fabricate microreactor array slides, work in a properly equipped semiconductor
fabrication cleanroom (Center for Solid State Electronics Research (CSSER),
Arizona State University, Tempe AZ). For biochemistry procedures, work in a
biosafety level 1 (BSL-1) laboratory (Center for Personal Diagnostics (CPD),
Biodesign Institute, Arizona State University, Tempe AZ). Work in a BSL-2 lab
(CPD) for serum screening assays. Acquire appropriate training and
certification for the facilities, procedures, equipment, chemicals, samples and
wastes. Obtain all chemicals from Sigma Aldrich (St. Luis MO) except where
noted.
Design photolithography mask for microreactor array slides.Generate a drawing for the
photolithography mask using computer aided design (CAD) software (AutoCad,
Autodesk, San Rafael CA). Draw a 150 mm diameter circle. Space seven microscope
slide format slides 25.4 mm3 76.2 mm apart within the circular outline. Add 50 mm
wide cut-lines ‘streets’ between slides for dicing. For each slide, draw,14,000 130 mm
diameter circles for the microreactors in a hexagonal closest packing array pattern
with 375 mm center-to-center spacing. Leave at least 1.33 mm empty areas, without
features, at the top and bottom of each slide. These areas are used for autofocus by the
microarray scanner. Put numbers along the sides and bottom of each slide to identify
rows and columns respectively. Include a logo along the bottom of each slide to orient
it during the various processing steps of printing, assaying and scanning. Add 200 mm
diameter circles outside of the slides for depth measurement during the etching
process.
Fabricate photolithography mask for microreactor array slides. Upload photolitho-
graphy mask drawing to mask manufacturer (JD Photo-Tools, Oldham UK). Specify
‘70 3 70 chrome glass’, ‘super-high resolution’ (128 K dpi), ‘darkfield’ and ‘design
viewed from glass side’. Fabricate the mask. Clear areas of the mask (no chrome)
correspond to the etched areas of the silicon wafer in subsequent steps.
Pattern silicon wafers. Obtain 60 (150 mm) silicon wafers (University Wafer,
Boston MA) with standard thickness of 675 mm 1/2 25 mm. Electrical properties
and crystal orientation of the silicon do not matter. Coat one side of each wafer
with 300 nm LPCVD low stress nitride. Spin coat nitride with 1 mm AZ 3312 (AZ
Electronic Materials Inc., Branchburg NJ) positive photoresist. Bake at 100uC for
two minutes. Expose photo resist with photolithography mask on mask aligner
(OAI, San Jose CA). Develop photoresist in AZ300 MIF developer (AZ Electronic
Materials Inc., Branchburg NJ) for 45 seconds and hard-bake at 100uC for
2 minutes. Selectively etch nitride film with reactive ion etch (RIE). Remove
photoresist with acetone.
Etch microreactors. Prepare HNA etchant mixture of 49% hydrofluoric acid (HF),
70% nitric acid (HNO3) and (.98%) glacial acetic acid (CH3COOH) in the ratio of
2.7551.7551. Isotropically etch wafers for,30 minutes to 70 mm depth and 270 mm
diameter. Etching silicon with HNA is exothermic so agitate the wafers to maintain
uniform temperature.
Grow oxide layer. Clean surface in piranha mixture (151 mixture sulfuric acid
(H2SO4): hydrogen peroxide (H2O2)) for 15 minutes. Clean surface in buffered oxide
etch of hydrofluoric acid (HF) and ammonium fluoride (NH4F) (156 mixture of
HF5NH4F) for 10 seconds. Grow 95 nm thin film silicon dioxide (SiO2) layer at
1,000uC for ,1 hour in oxygen furnace (Tystar 4600, Torrance CA).
www.nature.com/scientificreports
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Dice wafers.Dice wafers along cut-lines (Advotech Company, Inc., Tempe AZ) into 7
individual microreactor array slides. Saw blade kerf is 50 mm so actual slide dimen-
sions are 25.35 mm 3 76.15 mm.
Functionalize surfaces. Clean residual organic materials from the microreactor array
slides in piranha (151 mixture of H2S045H2O2) for 30 minutes. After rinsing with DI
water and drying with compressed air, immerse slides in 2% solution of (3-
Aminopropyl) triethoxysilane (APTES) in acetone for 30 minutes. Thoroughly rinse
slides in acetone and then DI water. Dry the slides with compressed air.
Print DNA into microreactors. Obtain plasmid DNA. Obtain a set of genes to be
printed from DNASU Plasmid Repository (Center for Personal Diagnostics,
Biodesign Institute, Arizona State University, Tempe AZ). Clones are sequence
verified and inserted in the E.Coli pDNR-dual recombinational cloning vector open
reading frames (ORFs) with the natural stop codon absent and GST-tag appended to
C-terminus.
Purify plasmid DNA.Grow E.Coli colonies of clone vectors. Harvest E.Coli and purify
plasmid DNA in 96 microreactor miniprep (Whatman Filter Plates, Sigma-Aldrich,
St. Louis MO). Transfer miniprep DNA to 384-well microplate.
Normalize plasmid DNA. Normalize miniprep plasmid DNA to 100 ng/ml
(Nanodrop 8000, Thermo Scientific, Wilmington DE).
Store plasmid DNA. Store plasmid DNA at 4uC until printing.
Prepare NAPPA printing-mixture. Prepare 1X printing-mixture. Thaw components
and keep them on ice. Mix components together in the following order and pro-
portions: 93% nuclease-free DEPC-treated water (Ambion, Life Technologies, Grand
Island NY), 0.6% BSA (Sigma-Aldrich), 1% anti-GST antibody (GE Healthcare), 5%
BS3 crosslinker (Thermo Scientific, Pierce). Keep mixture on ice. Age printing-
mixture at 4uC for one day to allow partial crosslinking of BS3. Aliquot printing-
mixture into 384-well microplate for printing. Keep microplate on ice until ready to
print.
Prepare microarray pattern. Predefine a microarray printing pattern for the 96 plas-
midDNA and the printing-mixture. Surround each spot containing printing-mixture
and plasmid DNA with 6 spots containing just the printing-mixture without the
plasmids. In this way, expressed proteins that diffuse away from a plasmid spot are
captured by the anti-GST antibodies in the printing-mixture of neighboring spots and
then easily detected.
Prepare bitmap pattern. For Figure 6 resize digital RGB image to 108 3 108 pixels
using function imresize() (Matlab, MathWorks, Natick MA). Using imrgb2ind()
reduce image to 5 uniformly spaced grayscale intensities, gray(5). Split image into two
halves to fit on a 10 3 30 microscope slide format. Convert to bitmap file using
imind2rgb().
Align microreactor array slides. Align APTES functionalized microreactor array
slides on the deck of a non-contact piezoelectric dispensing microarrayer
(Rainmaker-au302, Engineering Arts LLC, Tempe AZ). Use the au302 alignment
system to align the microreactors of the slides for continuous non-contact
dispensing.
Print microreactor array slides. Use either 8 or 16 piezoelectric dispensers
(Engineering Arts LLC, Tempe AZ) on the au302 microarrayer. Prime dispensers
with DI water. Place the 384-well microplate with printing-mixture on the deck of
the au302 microarrayer. Aspirate 2 ml printing-mixture into each dispenser using
on-head aspiration syringes. Dispense twelve 0.1 nl drops of printing-mixture in
short bursts at 12,500 drops-per-second into microreactors using the predefined
microarray pattern defined above. Use non-contact piezoelectric on-the-fly dis-
pensing at uniform print-head speed of 175 mm/sec. Dispense the same number
of drops with the same predefined pattern on flat microscope slides for Figure 2B.
Clean the piezoelectric tips by flushing DI water through the dispenser while the
dispenser tip is submerged in flowing DI water. Within 10 minutes, repeat the
same process with the 384-well microplate of plasmid DNA. Print 3 drops of
plasmid DNA in the same spots as the printing-mixture. Use the same aspirating
and dispensing parameters (12,500 drops-per-second) as for the printing-mixture.
Do not print plasmid DNA into the 6 surrounding microreactors containing just
printing-mixture alone. Repeat the process of dispensing printing-mixture fol-
lowed by plasmid DNA until all of 96 genes are printed. DNASU plate 4156
containing 96 general purpose genes was printed on the slide in Figure 2A. Print
on flat glass at the same time for Figure 2B. Print plasmid DNA for the p53 gene
onto the slide in Figure 6 using a PiXY piezoelectric microarrayer that prints
colored bitmaps.
Print flat glass slides for p53 serum screening comparison. Mix DNA and printing
mixture together. Print mixture on APTES coated glass microscope slides (Fischer
Scientific, Waltham MA, Cat. No. 12-544-1) using Genetix QArray2 pin-spotter at
2,500 spot density per microscope slide.
Store microarrays. Store printed plasmid DNAmicroarrays at room temperature in a
sealed container with desiccant. Printed plasmid DNA microarrays can be stored for
several months before protein expression.
Express proteins. Block microreactor array slides. This step also washes away
unbound printed molecules from slides’ surfaces. Program centrifuge (Beckman
Coulter model Allegra X-15R, Indianapolis IN) for 3750 RPM, maximum
acceleration andmaximumdeceleration. Submerge slides in a tray containing 8 ml of
Superblock Blocking Buffer in TBS (Thermo Scientific product #37535B, Rockford
IL). Accelerate up to themaximum speed and decelerate right away. Rinse slides in DI
water and dry them with compressed air.
Block glass slides. Use the same procedure as outlined above for microreactor array
slides. However, the centrifuge is not required since glass slide surfaces are flat so they
do not entrap air. Block slides for one hour on a rocking table (VWR model 200,
Radnor PA).
Prepare in vitro coupled transcription and translation (IVTT) reagent. Prepare IVTT
reagent from the ‘‘1-step human in vitro protein expression kit’’ (Thermo Scientific,
Rockford, IL). Thaw out the four components of the kit and keep them on ice. Mix
components in the following order and proportions: 34% HeLa lysate, 10% accessory
proteins, 22% reaction mix and 34% nuclease-free water. This uses 60% HeLa lysate
compared to the normal recipe. Keep mixture on ice. Degas lysate in a vacuum
desiccator until bubbles are gone in approximately 5 minutes.
Apply IVTT reagent to microreactor array slides. Insert a microreactor array slide
into the fill & seal device of Figure 1 (Biodesign Institute, ASU, Tempe AZ). Put
the O-ring around the slide. Place sealing membrane on top of the O-ring and
slide. Place window on top of the sealing membrane and clamp the fill & seal
device frame together using fasteners. Apply vacuum to the reagent outlet port
and inject 300 ml IVTT reagent into the inlet/outlet port. Inject pressurized sealing
liquid into the inlet port in the window to displace the reagent and seal the
microreactors.
Apply IVTT reagent to flat glass slides. Attach gasket (Hybriwell Sealing System item
440904, Grace Biolabs, Bend OR) to the slide. Using manual pipette, inject 150 ml
IVTT reagent into the hole at one end of the gasket.
Incubate glass slides. Incubate glass slides and gasket at 30uC in a chilling incubator
(EchoTherm chilling incubator, Torrey Pines Scientific, Carlsbad CA) for 1.5 hours
and then 15uC for 0.5 hours.
Incubate microreactor array slide. Incubate the fill & seal device assembly at 30uC in a
chilling incubator (EchoTherm chilling incubator, Torrey Pines Scientific, Carlsbad
CA) for 2 hours and then 15uC for 1 hour. Incubation times are longer than standard
NAPPA on glass slides to accommodate longer heating and cooling times due to the
higher thermal mass of the fill & seal device.
Detect fluorescent signals. Fluorescently label proteins. To preserve molecular
functionality, do not allow slides to dry out between processing steps. Prepare 5%
milk-PBST (0.2% Tween) blocking buffer. Combine 500 ml 1x phosphate
buffered saline (1 3 PBS) with 25 grams 100% instant nonfat powdered dry milk
and 1 ml Tween 20 detergent and mix with magnetic stirring bar for 10 minutes.
Store at 4uC. Fill a small tray with blocking buffer. Disassemble the fill & seal
device, remove the slide and submerge it into blocking buffer. Block for one hour
at room temperature on a rocking table (VWR model 200, Radnor PA) replacing
blocking buffer three times. For Figures 3 & 4, prepare primary label: mix 10 ml
mouse anti-GST monoclonal antibody (Cell Signaling Technologies, Danvers
MA) in 3 ml blocking buffer. Incubate slides in primary label overnight at 4uC on
a rocking table. Rinse slides with blocking buffer 3 times for 10 minutes each
time; replacing blocking buffer each time. Prepare secondary label: mix 6 ml
Alexa Fluor 647 nm goat anti-mouse IgG antibody (Life Technologies, Grand
Island NY) in 3 ml blocking buffer. Incubate slides in secondary label for 1 hour
at room temperature on a rocking table in the dark to prevent photo bleaching of
the fluorescent dye. Prepare rinsing buffer: 500 ml 1 3 PBS and 1 ml Tween.
Rinse slides in rinsing buffer three times for 1 minute each time; replacing the
rinsing buffer each time. Rapidly rinse slides in DI water 6 times replacing water
each time. Dry slides with compressed air. Store slides in the dark, at room
temperature with a desiccator.
Probe serum samples. Following protein expression, block slides in 5% milk-PBST
(0.2% Tween) on a rocking table at room temperature for 1 hour. For Figure 5,
incubate slides with diluted serum sample in proplate 4-well tray set (Grace Bio-Labs,
OR) at 4uC overnight.Wash slides in 5%milk-PBST (0.2%Tween) three times, 5 min
each time. Detect protein display with Alexa Fluor 647 labeled goat anti-human IgG
secondary antibody (Jackson ImmunoResearch, West Grove, PA). Finally, wash
slides in DI water and dry them with compressed air.
Image microreactor array slides. Program fluorescent microarray scanner
(PowerScanner, Tecan, Mannedorf Switzerland) for microreactor array slides.
Define coordinates of the empty areas at the top and bottom of slides for auto-
focus. Define reflectivity of those areas. Define 70 mm offset for microreactor
depth after autofocus. Apply self-adhesive 325 mm thick backing to slides to
accommodate 1 mm slide thickness requirement of the scanner. Scan slides at
10 mm resolution, 25% laser power (out of 30 mW) and 25% (out of 800%
maximum) photo multiplier tube (PMT) detector gain. Extract data (Array-Pro,
Media Cybernetics, Rockville MD). Analyze data (Excel, Microsoft, Redmond
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WA). Plot signal to background ratio of anti-P53 response, Figure 5. Signal for
each dilution point is the average signal of six spots on the array. Signal of each
spot is the median pixel value of that spot. Background is the median signal of all
of the spots on the array.
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